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Objective: On-pump beating heart coronary artery surgery provides the opportunity
to examine the isolated effect of cardiopulmonary bypass. This prospective randomized
study compares the early clinical outcomes and inflammatory response of patients
undergoing elective on-pump and off-pump beating heart coronary artery bypass
grafting.
Method and Patients: Thirty-seven consecutive patients undergoing elective coronary
artery bypass grafting were recruited from a pool of 73 patients, with 19 patients
randomized to on-pump beating heart surgery and 18 patients to off-pump coronary
bypass surgery. Intraoperative events and postoperative outcomes were recorded.
Plasma levels of interleukin-6, interleukin-8, and interleukin-10, tumor necrosis factor-
alpha, and vascular cell adhesion molecule-1 were measured before the operation,
intraoperatively, after the operation, and 4, 24, and 48 hours thereafter.
Results: There was no significant difference in clinical outcomes between the 2
groups. The operating time was longer and consumption of platelets was greater for
the on-pump beating heart group. There was no postoperative mortality or major
complication in either group. There was significant elevation in the levels of
interleukin-6, interleukin-8, and interleukin-10 and tumor necrosis factor-alpha
during and immediately after the operations in the on-pump beating heart group
when compared with the off-pump group. Levels of interleukin-8 (P  .01) and
tumor necrosis factor-alpha (P  .0004) remained significantly elevated 4 hours
after the operation in the on-pump beating heart group. The level of vascular
adhesion molecule dropped significantly during the operation but was elevated 4
hours (P  .026) after the operation in the on-pump beating heart group.
Conclusion: The use of cardiopulmonary bypass alone without global myocardial
ischemia secondary to aortic crossclamping and cardioplegic cardiac arrest can
trigger intense inflammatory responses.
There has been a resurgence of interest in off-pump coronary arterybypass (Off-PCAB) in the last decade, and the advantages associatedwith the use of this technique have been repeatedly emphasized.Controversies still exist concerning the benefits of Off-PCAB whencompared with conventional coronary artery bypass grafting(CABG).1-3 The morbidities of conventional CABG include the use
of cardiopulmonary bypass (CPB), cardioplegic arrest, and manipulation of aorta
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and median sternotomy as surgical access. Off-PCAB elim-
inated the use of CPB and cardioplegic arrest. The use of
CPB has been shown to provoke systemic inflammatory
response syndrome and is associated with the release of
cytokines and activation of complements.4-6 Off-PCAB
does not mean elimination of the heart-lung machine alone.
This technique also eliminates global myocardial ischemia
during aortic crossclamping and reperfusion after cardiople-
gic arrest.7 Another important difference in off-pump sur-
gery is the continuous ventilation of the lungs during the
operation. The ventilation is usually stopped during conven-
tional CABG performed with CPB. We have studied the
cytokine responses using different methods of myocardial
protection and even with intermittent aortic crossclamping
with fibrillation8 but the isolated effect of the heart-lung
machine on the body has never been elucidated. The tech-
nique of on-pump beating heart coronary artery bypass
(On-PCAB) has been reported as an acceptable trade-off
between conventional CABG with cardioplegic arrest and
Off-PCAB in selected high-risk patient.9 With on-pump
beating heart technique and continuous ventilation we could
investigate the isolated effect of the CPB machine on the
body’s inflammatory response without the influence of isch-
emic reperfusion secondary to cardioplegic arrest. A pro-
spective randomized study was conducted to compare the
clinical outcomes and inflammatory response of patients
undergoing elective Off-PCAB and On-PCAB.
Patients and Methods
Thirty-seven consecutive patients undergoing elective CABG were
recruited from a pool of 73 patients. Patients with recent myocar-
dial infarction, unstable angina, on steroid treatment, age 75,
serum creatinine 200 mol/L, single-vessel disease, previous
open cardiac procedures, and poor left ventricular function (ejec-
tion fraction  30%) were excluded. With ethical committee
approval, written informed consent was obtained from all patients.
A randomization table was generated with a computer, and the
results were concealed in sealed opaque envelopes. Both the pa-
tients and the surgeons were unaware of the result of randomiza-
tion until the patient was put under general anesthesia and the
sealed envelope was opened. One surgeon performed all the op-
erations.
Anesthetic Technique
Standard anesthetic techniques were employed in all cases with
intravenous propofol combined with sufentanil and midazolam.
Muscle relaxation was achieved with pancuronium. Prophylatic
antibiotic Cefuroxime (GlaxoSmithKline, Hong Kong, China;
1.5 g) was given on induction and followed by 750 mg every 8
hours for 24 hours. Ventilation was maintained throughout the
operation for both groups of patients. For the On-PCAB group,
heparin was given at a dose of 3 mg/kg with activated clotting time
(ACT) greater than 480 seconds while 1.5 mg/kg of heparin was
given for the Off-PCAB group, keeping ACT within the range of
250 to 350.
Full-dose heparin (3 mg/kg) was given when ACT was greater
than 480 seconds. Mean perfusion pressure was kept at 60 mm Hg
and patient was kept warm throughout the procedure. On comple-
tion of CPB, protamine was given to neutralize the heparin.
Surgical Technique
Median sternotomy was used as the surgical access in all cases.
Left internal thoracic arteries were harvested in all cases and radial
arteries or saphenous veins were used as other conduits. In both
Off-PCAB and On-PCAB groups, cardiac displacement was
achieved by using a half-folded swab being snared down to the
posterior pericardium between the left inferior pulmonary vein and
inferior vena cava. The swab was used to lift the heart out of the
pericardial cradle.10 The target vessels were exposed and con-
trolled with silastic sling. Stabilization was achieved with the
compression type of stabilizer (Guidant, Santa Clara, Calif). The
target vessel was then opened and an intracoronary shunt (Flothru
Biovascular Inc, St Paul, Minn) was put in to maintain distal
perfusion during the performance of anastomosis. Visualization of
the operative field was achieved with carbon dioxide surgical
blower system. All proximal anastomoses were performed with the
use of side-biting aortic clamp. For the On-PCAB group, standard
CPB technique was employed with ascending aortic cannulation
and venous drainage via 2-stage venous cannula within the right
atrium. The circuit consisted of a roller pump (Stockert, GmBH,
Germany) and a membrane oxygenator (Capriox SX, Terumo,
Mich).
Cytokine and Biochemical Measurements
Blood samples were taken before the procedure, on completion of
distal anastomosis for the Off-PCAB group and on completion of
CPB for On-PCAB group, on skin closure, and 4, 12, and 24 hours
after the operations. All blood samples were immediately cooled to
4°C and centrifuged (3000g for 10 minutes at 4°C). The plasma
was separated and stored at 70°C until assay. Levels of tumor
necrosis factor-alpha (TNF-), interleukin (IL)-6, IL-8, IL-10, and
vascular adhesion molecule-1 (VCAM-1) were determined by
means of commercially available enzyme-linked immunosorbent
assays (R&D Systems, Minneapolis, Minn).
Statistical Methods
All data were stored and analyzed using a standard computer
statistical software program (Statistical Package for the Social
Sciences 11.0; SPSS Inc, Chicago, Ill) and MIXREG computer
software.11 Clinical data were shown as mean  standard devia-
tion. Unpaired t test and chi-square test were used for comparing
clinical variables between the 2 groups. Mixed-effects models
(multilevel models) were used for analyzing longitudinal data12 by
comparing the cytokine and adhesion molecule levels between the
2 groups at each of the 6 time points. The mixed-effects model is
considered to be an extension of the ordinary least-squares regres-
sion model but also takes into account subject heterogeneity. The
statistical analysis was performed on raw data and logarithmically
transformed results where appropriate to correct the skewness of
the data. Values of those biochemical data are expressed as mean
 standard error of the mean.
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The Off-PCAB and On-PCAB groups were comparable in
terms of age, sex, functional class, and number of disease
coronary vessels (Table 1). There was no major complica-
tion in either group and no patient required reexploration for
bleeding. The mean number of grafts was 2.44  0.51 for
the Off-PCAB group and 2.79  0.54 for On-PCAB group
(Table 2). The operating time was significantly longer for
the On-PCAB group (mean  167.10  36.91 minutes)
when compared with the Off-PCAB group (mean  143.61
 29.2; P  .038. There was no 30-day mortality for either
group. None of the patients suffered from postoperative
myocardial infarction, cerebrovascular accident, renal fail-
ure, or low cardiac syndrome. There was no significant
statistical difference in the frequency of atrial fibrillation or
flutter between the 2 groups (P  1.00).
Cytokines and Adhesion Molecules
Levels of IL-6 were raised in both groups during and after
the operations. IL-6 levels were significantly higher in the
On-PCAB group intraoperatively and immediately after the
operation when compared with the Off-PCAB group (P 
.0023, P  .0002, respectively; Figure 1). IL-8 levels were
significantly higher in the On-PCAB group but the differ-
ence disappeared 24 hours after the operation (P .0001, P
 .0001, and P  .01, respectively; Figure 2). IL-10 levels
were elevated in both groups but the levels were signifi-
cantly higher in the On-PCAB group during and immedi-
ately after the operation (P  .0001 and P  .0001, respec-
tively; Figure 3). TNF- levels were significantly elevated
in the On-PCAB group during the operation, immediately
after, and 4 hours after (P  .0001, P  .0001, and P 
.0004, respectively; Figure 4). There was a drop in the
VCAM-1 levels during the operation in the On-PCAB
group (P  .0006) but significantly higher levels were
observed 4 hours after the operation when compared with
the Off-PCAB group (P  .026; Figure 5).
Discussion
The morbidities of conventional CABG have been attrib-
uted to the use of CPB, cardioplegic arrest, and aortic
crossclamping resulting in ischemia and reperfusion. The
development of off-pump CABG served to eliminate the
harmful effects of the heart-lung machine together with
cardioplegia. The clinical and biochemical benefits of off-
pump surgery have been demonstrated in various clinical
trials.3-5 On-pump beating heart coronary operations have
been described as an acceptable trade-off in high-risk pa-
tients as manipulation of the heart during off-pump grafting
would lead to significant hemodynamic compromise with
decrease in cardiac output and stroke volume.9 No random-
ized prospective study is available in the current literature
that investigates the effect of CPB in isolation. This study
serves to eliminate the effects of global myocardial isch-
emic arrest using aortic crossclamping and cardioplegic
arrest and allows observation of the clinical and biochemi-
cal consequences of on-pump beating heart coronary oper-
ations.
TABLE 1. Patient characteristics
Preoperative variables Off-PCAB (n  18) On-PCAB (n  19) P value
Male sex 15 11 .15











Hypertension 13 15 .71
Diabetes 7 6 .73
Hyperlipidemia 12 15 .48
Smoking 11 6 .10
Family history of ischemic heart disease 6 3 .27
History of myocardial infarction 4 3 .69
Number of disease vessels* 2.44 0.51 2.74 0.45 .075
Ejection fraction* 52.93 13.58 50.42 12.04 .57
NYHA, New York Heart Association; Off-PCAB, off-pump coronary artery bypass; On-PCAB, on-pump beating heart coronary artery bypass.
*Mean  standard deviation.
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We and other groups have demonstrated the association
of reduced proinflammatory response with the off-pump
technique.3-5 In this study we showed that the use of CPB in
isolation without the effect of global myocardial ischemia
was associated with the rise in proinflammatory cytokines
and adhesion molecules. CPB is the major factor in trigger-
ing the inflammatory response during CABG. However, we
could not demonstrate any significant clinical outcomes
between the 2 groups of patients except the greater require-
ment of platelet transfusion for the On-PCAB group (Table
3). The operating time was longer for the On-PCAB group
as extra time was needed for the setup of CPB and cannu-
lation.
The contact of blood with CPB surface, ischemia and
reperfusion, and surgical trauma can trigger the release of
inflammatory mediators including complements and cyto-
TABLE 2. Perioperative variables
Perioperative variables Off-PCAB (n  18) On-PCAB (n  19) P value
Operation time (min)* 143.61 29.20 167.10 36.91 .038
Number of grafts* 2.44 0.51 2.79 0.54 .053
Postoperative bleeding 0 0
Blood loss (mL in 24 hours)* 701.17 243.71 748.16 305.94 .61
Time to extubation (hours)* 6.08 2.52 7.32 2.60 .15
Duration of ICU stay (hours)* 18.94 4.57 18.74 2.88 .87
Postoperative MI 0 0
Atrial fibrillation/flutter 2 3 .661
Ventricular fibrillation/tachycardia 0 0
Postoperative stroke 0 0
Postoperative renal failure 0 0
Use of intra-aortic balloon pump 0 0
Low cardiac output syndrome 0 0
Length of hospital stay (days)* 6.06 1.21 6.26 0.99 .57
Off-PCAB, Off-pump coronary artery bypass; On-PCAB, on-pump beating heart coronary artery bypass; ICU, intensive care unit; MI, myocardial infarction.
*Mean  standard deviation.
Figure 1. IL-6 (pg/mL) in patients receiving On-PCAB (n  19) and Off-PCAB (n  18) over the study period. The
asterisks indicate significant rate of change in IL-6 compared with preoperative concentration between the 2
groups. Preop, Preoperative; Intraop, intraoperative; Postop, immediately postoperative and 4, 24, and 48 hours after
the operation. Data are given as means  SEM.
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Figure 3. IL-10 (pg/mL; loge) in patients receiving On-PCAB (n  19) and Off-PCAB (n  18) over the study period.
The asterisks indicate significant rate of change in IL-10 compared with preoperative concentration between the
2 groups. Preop, Preoperative; Intraop, intraoperative; Postop, immediately postoperative and 4, 24, and 48 hours
after the operation. Data are given as means  SEM.
Figure 2. IL-8 (pg/mL; loge) in patients receiving On-PCAB (n  19) and Off-PCAB (n  18) over the study period.
The asterisks indicate significant rate of change in IL-8 compared with preoperative concentration between the
2 groups. Preop, Preoperative; Intraop, Intraoperative; Postop, immediately postoperative and 4, 24, and 48 hours
after the operation. Data are given as means  SEM.
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Figure 5. VCAM-1 (ng/mL) in patients receiving On-PCAB (n 19) and Off-PCAB (n 18) over the study period. The
asterisks indicate significant rate of change in VCAM-1 compared with preoperative concentration between the
2 groups. Preop, Preoperative; Intraop, intraoperative; Postop, immediately postoperative and 4, 24, and 48 hours
after the operation. Data are given as means  SEM.
Figure 4. TNF- (pg/mL; loge) in patients receiving On-PCAB (n  19) and Off-PCAB (n  18) over the study period.
The asterisks indicate significant rate of change in TNF- compared with preoperative concentration between the
2 groups. Preop, Preoperative; Intraop, intraoperative; Postop, immediately postoperative and 4, 24, and 48 hours
after the operation. Data are given as means  SEM.
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kines.13. The nuclear factor kB is activated by the release of
cytokines and subsequently translocated to the nucleus, and
the expression of several inflammatory mediators is in-
duced. The expression of adhesion molecules including
intercellular adhesion molecule and VCAM is upgraded by
the release of cytokines. The binding of adhesion molecules
with the integrins triggers the firm adhesion of leukocytes
on the endothelial cells. The leukocytes can migrate across
the endothelial cells into the interstitial space, releasing free
oxygen free radicals, arachidonic acid metabolites, and pro-
teases.13 All these result in endothelial dysfunction and may
be associated with postoperative complications after cardiac
surgery. Our study shows that the contact of blood with the
CPB surface appears to be the most important factor in the
initiation of the systemic inflammatory response with sur-
gical trauma and ischemia and reperfusion playing a less
important role.
IL-6, IL-8, and TNF- are proinflammatory cytokines
and their increase was previously shown to be associated
with hemodynamic instability and myocardial dysfunction
after CPB.14 The rise in IL-6 was observed in both groups
of patients as the release of IL-6 was associated with sur-
gical trauma. However, there was still significant difference
in the rise of IL-6 levels intraoperatively and immediately
after the operation. It has been shown that ischemia and
reperfusion result in induction of IL-6 mRNA production by
cardiac myocytes.15 In situ hybridization studies confirmed
that myocardium was a principal source of IL-6 synthesis
after cold cardioplegic arrest and CPB.16 Our study shows
that with CPB alone without cardioplegia, significantly
higher levels of IL-6 can be detected during the operation
when compared with the off-pump group.
IL-8 was shown to be released from the myocardium
during ischemia and reperfusion.17 We have previously
demonstrated the positive correlation between the cardiac
troponin I and elevated IL-8 levels after cardiac surgery.4
Our study shows that CPB alone without ischemia and
reperfusion can result in a significant rise in IL-8.
TNF- level rose significantly during and after the CPB
operations. This result further supports the fact that the
heart-lung machine is the main trigger of proinflammatory
cytokines, which we failed to demonstrate in our previous
study.4 The myocardium has been implied as the source of
TNF- release after ischemia-reperfusion injury in experi-
mental studies and it was shown to inhibit hamster papillary
muscles in a dose-dependent manner.18
Induction of IL-10 was demonstrated in reperfused myo-
cardium following ischemia, and it helped to suppress the
acute inflammatory response by modulating macrophage-
cytokine function and promote metabolic steps associated
with tissue repair.19 The release of IL-10 is lower during
off-pump surgery when compared with the on-pump beating
heart surgery. The lower release of this anti-inflammatory
cytokine for the off-pump group may be related to the less
intense proinflammatory response. Accumulating evidence
shows that the balance between pro- and anti-inflammatory
mediators is crucial in determining the outcome of inflam-
matory injury.4,20,21 As most of these pro- and anti-inflam-
matory cytokines were produced by the myocardium, car-
dioplegic arrest and reperfusion could result in direct
myocardial injury with induction of all these cytokines.
Theoretically, with elimination of the ischemia-reperfusion
insult imposed by cardioplegia and aortic crossclamping, all
these cytokine responses should be attenuated. However, we
show that use of CPB alone with both lungs being ventilated
results in a significant rise in all the cytokines, but we
cannot prove whether the myocardium is the source, as
previous study showed. Further studies including coronary
sinus blood sampling of cytokines may help to determine
the source of the cytokines, and currently we have no
evidence of cytokine release from myocardium under the
influence of nonpulsatile flow with the use of CPB alone.
Circulating soluble adhesion molecules from endothelial
cells were considered to be the reflection of cellular activa-
tion and damage.22 VCAM-1 belongs to the group of trans-
membrane glycoproteins of the immunoglobulin superfam-
ily expressed by the endothelial cells. It serves as a ligand
for leukocyte integrins.23 Serum VCAM-1 was demon-
strated to be a very early marker of endothelial activation
and damage caused by CPB. The release of VCAM-1 has
been shown to be related to the use of CPB and also to
ischemia and reperfusion after cardioplegic arrest.24 We
showed that there was a rise in the level of VCAM-1 4 hours
after the operation with CPB alone without the use of
cardioplegia in the aortic crossclamping group but we could
not explain a why there was a drop in VCAM-1 level
intraoperatively for the On-PCAB group. It is unclear
whether the rise in the VCAM-1 level is secondary to
increased cellular expression or shedding from the cells.
Recent study has supported the cleavage of cell-surface
adhesion molecule rather than increased endothelial cell
synthesis or expression. IL-10 can suppress adhesion mol-
ecule expression25 and can possibly explain the normaliza-
tion of VCAM-1 24 hours after the operation. The rise in the
VCAM-1 levels appears to be delayed when compared with
other inflammatory cytokines. This can be explained by the





(n  19) P value
Blood (units)* 0.44 0.86 1.11 1.41 .093
Fresh frozen plasma
(units)*
0.15 0.49 1.70 0.73 .108
Platelets (units)* 0.33 0.76 2.26 1.56 .01
*Mean  standard deviation.
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fact that the activation of VCAM-1 consists of 2 phases
involving gene regulation and induction of protein synthe-
sis.26
The use of CPB alone has been shown to be associated
with a significant rise in the inflammatory response when
compared with off-pump coronary artery bypass surgery. It
seems that the modification of different cardioplegic tech-
niques without elimination of CPB may not be helpful in
abolishing the body’s inflammatory response. The increase
in systemic inflammatory response results in leukocyte ex-
travasation, tissue damage, myocardial suppression, and
ultimately organ failure. Any strategy that reduces systemic
inflammatory response can theoretically minimize the mor-
bidities associated with coronary artery surgery.
Conclusion
The use of CPB alone without global myocardial ischemic
arrest secondary to aortic crossclamping and cardioplegia
can trigger intense inflammatory responses.
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